Skip to main content


35 result(s) for 'author#Paolo Calabresi' within BMC

Page 1 of 2

Sort by: Relevance | Date

  1. Medication overuse headache (MOH) is a clinically important entity and it is now well documented that the regular use of acute symptomatic medication by people with migraine or tensiontype headache increases t...

    Authors: P. Calabresi and L. M. Cupini
    Citation: The Journal of Headache and Pain 2005 6:184
  2. Following publication of the original article [1], the authors reported an error in the affiliation of the third author, Sara Gandini. The correct affiliation should read: Division of Epidemiology and Biostati...

    Authors: Massimiliano Ruscica, Chiara Pavanello, Sara Gandini, Chiara Macchi, Margherita Botta, Daria Dall’Orto, Marina Del Puppo, Marco Bertolotti, Raffaella Bosisio, Giuliana Mombelli, Cesare R. Sirtori, Laura Calabresi and Paolo Magni
    Citation: Nutrition Journal 2019 18:54

    The original article was published in Nutrition Journal 2019 18:13

  3. Chronic migraine is a disabling condition that is currently underdiagnosed and undertreated. In this narrative review, we discuss the future of chronic migraine management in relation to recent progress in evi...

    Authors: Elio Clemente Agostoni, Piero Barbanti, Paolo Calabresi, Bruno Colombo, Pietro Cortelli, Fabio Frediani, Pietrangelo Geppetti, Licia Grazzi, Massimo Leone, Paolo Martelletti, Luigi Alberto Pini, Maria Pia Prudenzano, Paola Sarchielli, Gioacchino Tedeschi and Antonio Russo
    Citation: The Journal of Headache and Pain 2019 20:92
  4. We tested the computerised, structured medical record by entering and analysing the consecutive clinical sheets of primary headaches in the episodic forms (200) and chronic headache (200) and the corresponding...

    Authors: P. Sarchielli, M. Pedini, A. Alberti, A. Baldi, I. Corbelli and P. Calabresi
    Citation: The Journal of Headache and Pain 2005 6:186
  5. Lysosomal dysfunction is thought to be a prominent feature in the pathogenetic events leading to Parkinson’s disease (PD). This view is supported by the evidence that mutations in GBA gene, coding the lysosomal h...

    Authors: Davide Chiasserini, Silvia Paciotti, Paolo Eusebi, Emanuele Persichetti, Anna Tasegian, Marzena Kurzawa-Akanbi, Patrick F Chinnery, Christopher M Morris, Paolo Calabresi, Lucilla Parnetti and Tommaso Beccari
    Citation: Molecular Neurodegeneration 2015 10:15
  6. Neuroacanthocytosis (NA) denotes a heterogeneous group of diseases that are characterized by nervous system abnormalities in association with acanthocytosis in the patients' blood. The 4.1R protein of the eryt...

    Authors: Antonio Orlacchio, Paolo Calabresi, Adriana Rum, Anna Tarzia, Anna Maria Salvati, Toshitaka Kawarai, Alessandro Stefani, Antonio Pisani, Giorgio Bernardi, Paolo Cianciulli and Patrizia Caprari
    Citation: BMC Neurology 2007 7:4
  7. Medication overuse headache (MOH) is a very heterogeneous disorder for which a recommended treatment is not yet available. The purpose of this study was to investigate any possible roles of demographic and cli...

    Authors: Stefano Caproni, Elisa Bianchi, Letizia M Cupini, Ilenia Corbelli, Ettore Beghi, Paolo Calabresi and Paola Sarchielli
    Citation: The Journal of Headache and Pain 2014 15:88
  8. The introduction of monoclonal antibodies (mAbs) against calcitonin-gene related peptide (CGRP) or CGRP receptors in the treatment of migraine raised concerns on the possible risks associated to the long-term ...

    Authors: Giuseppe Tringali, Catello Vollono, Paolo Calabresi and Pierluigi Navarra
    Citation: The Journal of Headache and Pain 2020 21:124
  9. The management of Medication overuse headache (MOH) represents a difficult challenge for clinicians and headache experts, particularly for the responder rate after a successful withdrawal treatment. The purpos...

    Authors: Stefano Caproni, Elisa Bianchi, Letizia M. Cupini, Ilenia Corbelli, Ettore Beghi, Paolo Calabresi and Paola Sarchielli
    Citation: BMC Neurology 2015 15:85
  10. Hemiplegic migraine (HM) is a rare form of migraine characterized by the presence of a motor and other types of aura. HM can be sporadic or familial. Familial hemiplegic migraine (FHM) is an autosomal dominant...

    Authors: Marina Romozzi, Guido Primiano, Eleonora Rollo, Lorena Travaglini, Paolo Calabresi, Serenella Servidei and Catello Vollono
    Citation: The Journal of Headache and Pain 2021 22:85